Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven

SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our stud...

Full description

Bibliographic Details
Main Authors: Nestor S. Martins, Daniel S.S. Mello, Joaquim Barreto, Alexandre A.S. Soares, Ikaro Breder, Jessica Cunha, Wilson Nadruz, Otavio R. Coelho Filho, José Roberto Matos-Souza, Otavio R. Coelho, Daniel B. Munhoz, José Carlos Quinaglia e Silva, Andrei C. Sposito, Luiz Sergio F Carvalho
Format: Article
Language:English
Published: Associação Médica Brasileira
Series:Revista da Associação Médica Brasileira
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003&lng=en&tlng=en
id doaj-9fbb4cb3ccad4185a6187c0e49ded33b
record_format Article
spelling doaj-9fbb4cb3ccad4185a6187c0e49ded33b2020-11-24T21:33:24ZengAssociação Médica BrasileiraRevista da Associação Médica Brasileira1806-92826513810.1590/1806-9282.65.1.3S0104-42302019000100003Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heavenNestor S. MartinsDaniel S.S. MelloJoaquim BarretoAlexandre A.S. SoaresIkaro BrederJessica CunhaWilson NadruzOtavio R. Coelho FilhoJosé Roberto Matos-SouzaOtavio R. CoelhoDaniel B. MunhozJosé Carlos Quinaglia e SilvaAndrei C. SpositoLuiz Sergio F CarvalhoSUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003&lng=en&tlng=enDyslipidemiasDiabetes mellitusRisk factorsTargets
collection DOAJ
language English
format Article
sources DOAJ
author Nestor S. Martins
Daniel S.S. Mello
Joaquim Barreto
Alexandre A.S. Soares
Ikaro Breder
Jessica Cunha
Wilson Nadruz
Otavio R. Coelho Filho
José Roberto Matos-Souza
Otavio R. Coelho
Daniel B. Munhoz
José Carlos Quinaglia e Silva
Andrei C. Sposito
Luiz Sergio F Carvalho
spellingShingle Nestor S. Martins
Daniel S.S. Mello
Joaquim Barreto
Alexandre A.S. Soares
Ikaro Breder
Jessica Cunha
Wilson Nadruz
Otavio R. Coelho Filho
José Roberto Matos-Souza
Otavio R. Coelho
Daniel B. Munhoz
José Carlos Quinaglia e Silva
Andrei C. Sposito
Luiz Sergio F Carvalho
Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
Revista da Associação Médica Brasileira
Dyslipidemias
Diabetes mellitus
Risk factors
Targets
author_facet Nestor S. Martins
Daniel S.S. Mello
Joaquim Barreto
Alexandre A.S. Soares
Ikaro Breder
Jessica Cunha
Wilson Nadruz
Otavio R. Coelho Filho
José Roberto Matos-Souza
Otavio R. Coelho
Daniel B. Munhoz
José Carlos Quinaglia e Silva
Andrei C. Sposito
Luiz Sergio F Carvalho
author_sort Nestor S. Martins
title Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_short Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_full Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_fullStr Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_full_unstemmed Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_sort prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
publisher Associação Médica Brasileira
series Revista da Associação Médica Brasileira
issn 1806-9282
description SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.
topic Dyslipidemias
Diabetes mellitus
Risk factors
Targets
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003&lng=en&tlng=en
work_keys_str_mv AT nestorsmartins prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT danielssmello prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT joaquimbarreto prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT alexandreassoares prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT ikarobreder prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT jessicacunha prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT wilsonnadruz prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT otaviorcoelhofilho prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT joserobertomatossouza prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT otaviorcoelho prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT danielbmunhoz prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT josecarlosquinagliaesilva prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT andreicsposito prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT luizsergiofcarvalho prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
_version_ 1725953410934505472